Listen as aesthetic experts Douglas Wu, MD, PhD and William Kwan, MD share their experiences with the new Picoway® 730 nm and Resolve Fusion 532 nm handpieces from Candela.
Why should physicians attend the next APAC User Meeting?
This past fall, Syneron-Candela hosted its APAC User Meeting in Seoul, South Korea. We asked a couple of physicians who attended the conference to summarize the value of attending. Here is what we learned.
“The Syneron-Candela APAC conferences are superbly run, and the speakers are all experts with the equipment. They are from the APAC region, their scientific approach is impressive, and they are an interesting change from the usual speakers one hears on the international circuit. I learned new developments in the treatment of complex pigmentation in darker skin types with picosecond lasers. Also, I learned more information about the new VBeam Prima system.
The opportunity to meet and speak with members of the Syneron-Candela Engineering team that have developed the lasers is also extremely interesting and a wonderful opportunity to give feedback.”
– Philip Bekhor, M.D.
Director, Laser Unit, Department of Dermatology, Royal Children’s Hospital, Melbourne Victoria, Australia
“I learned about the long pulse Nd:YAG laser (Gentle Yag), which can be useful for superficial pigmentation and some melasma treatment. I also learned how the Profound system can be very useful for wrinkle reduction and the appearance of cellulite and with patient satisfaction for both body and face treatments. I enjoy the APAC User Meeting because I always learn something from my excellent colleagues. It’s valuable to learn about the many different Syneron-Candela devices and to learn from peers about new treatment parameters, outcome data and post-treatment care data.
– Peter Hsien-Li Peng, M.D.
Founder and Director, P-Skin Professional Clinic, Taiwan
“We learned approaches from other key opinion leaders (KOLs) and adapted their parameters. When we integrate the knowledge from this KOL meeting, patients will definitely receive better treatment.”
– Wichai Hongcharu, M.D.
Chief of Dermatology Unit of Saint Louis Hospital, Bangkok, Thailand